Analysis reveals that POCT and telemedicine improve screening for type 2 diabetes, highlighting patient-centered care benefits.
Diabetes is a chronic metabolic disorder of growing global concern. By 2030, it is projected to affect 643 million individuals worldwide. Early identification and management are essential to prevent complications and reduce healthcare costs. This study investigates the effectiveness of a screening strategies using Point- of care testing (POCT) and telemedicine to identify individuals at risk for type 2 diabetes. This study evaluates the effectiveness of screening strategies using Point-of-Care Testing (POCT) and telemedicine in identifying individuals at risk for type 2 diabetes. A sample of 80 individuals aged 45 to 65 was evaluated using capillary blood, to glucose levels testing and risk scoring questionnaires. By reducing the negative consequences of diabetes mismanagement the patient’s quality of life will increase in addition to a reduction in the cost of healthcare. In recent years, the advancement of modern technology as a whole has favored a more patient-centric care approach. Our findings support the efficacy of POCT and telemedicine as tools for early detection, patient engagement and disease management.
No takes yet. Share an insight, caveat, or question.
Tripodi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: